These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3869114)

  • 61. [Effect of cefotaxime in the treatment of infections associated with hematologic diseases].
    Kaneko H; Masaki T; Yamaguchi R; Takahashi N; Umeda M; Shirai T
    Jpn J Antibiot; 1983 Sep; 36(9):2502-14. PubMed ID: 6317914
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Clinical trial of a new broad-spectrum cephalosporin: HR 756 (cefotaxime)].
    Poletti T; Bertola D; Pellerito R; Soragna A
    Minerva Med; 1980 Jul; 71(27):1935-43. PubMed ID: 6248823
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Effect of a treatment with methisoprinol on the frequency and duration of infectious respiratory and urinary episodes in the elderly].
    Meroni PL; Palmieri R; Palmieri G; Froldi M; Zanussi C
    Recenti Prog Med; 1984 Dec; 75(12):1081-8. PubMed ID: 6084859
    [No Abstract]   [Full Text] [Related]  

  • 64. Ceftizoxime in the treatment of hospital-acquired respiratory infections. Ceftizoxime Pneumology Italian Study Group.
    Garotta F; Messa A; Pamparana F
    J Chemother; 1991 Feb; 3 Suppl 2():25-6. PubMed ID: 2040895
    [No Abstract]   [Full Text] [Related]  

  • 65. [Efficacy and tolerability of cefoperazone in patients with nosocomial infections].
    Albano O; Palasciano G; Morelli N; Monno D; Velardi A; Tardi S; Malvestiti FM
    Clin Ter; 1988 Jul; 126(2):97-100. PubMed ID: 2974382
    [No Abstract]   [Full Text] [Related]  

  • 66. [Cost-effectiveness comparative study of ceftriaxone verus cefotaxime in the treatment of complicated urinary infections].
    Martínez Jabaloyas JM; Sanz Chinesta S; Jiménez Cruz JF; Flores Corral N; Unda Urzaiz M; Leiva Galvis O; González Romojaro V; Hernández Fernández C; Lledó García E; Rioja Sanz LA; Gonzalvo Ibarra A; Camacho González JE; Ruíz Alvárez-Cienfuegos F; Resel Estévez L; Corral Saleta J; Burgos Rodríguez R; Del Rosal Samaniego JM
    Actas Urol Esp; 1997; 21(7):668-74. PubMed ID: 9412209
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Clinical evaluation of cefotiam in adults urinary tract infections (author's transl)].
    Guibert J; Coppens H; Yvelin C
    Pathol Biol (Paris); 1982 Jun; 30(6):353-6. PubMed ID: 6287388
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacokinetic study of cefodizime in experimentally infected animals.
    Arai S; Tabata S; Kobayashi S; Inazu M; Hayashi S
    Arzneimittelforschung; 1989 Aug; 39(8):877-82. PubMed ID: 2818675
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [The treatment of bacterial respiratory and urinary tract infections with cefazedone. Clinical proof of effectiveness and tolerance].
    Schneiderhan H; Buchegger G
    Fortschr Med; 1981 Mar; 99(12):435-8. PubMed ID: 7227942
    [No Abstract]   [Full Text] [Related]  

  • 70. Therapeutic efficacy and tolerability of cefotaxime--a study of acute respiratory infections in chronic lung conditions.
    Shah SP; Mehta AP; Shetty SR; Mahashur AA; Kamat SR
    J Postgrad Med; 1988 Jan; 34(1):15-20. PubMed ID: 3385652
    [No Abstract]   [Full Text] [Related]  

  • 71. [Association of trimethoprim-sulfamethoxazole in respiratory and urinary tract infections].
    Rimondini S; Malaguti P
    Minerva Med; 1972 Apr; 63(29):1679-85. PubMed ID: 5025775
    [No Abstract]   [Full Text] [Related]  

  • 72. [Clinical tests of a new antibiotic (Sevilmine) in respiratory and urinary infections of chronic patients].
    Peãn y Barquin J; Gómez Rubí JA; Laín Martínez P
    Rev Clin Esp; 1968 Feb; 108(3):198-205. PubMed ID: 5740494
    [No Abstract]   [Full Text] [Related]  

  • 73. Cefotaxime in the management of acute lower respiratory tract infection.
    Keelan P; Hone R; Martin L; Callaghan B; Harty M
    Ir Med J; 1982 May; 75(5 Suppl):6-7. PubMed ID: 6284676
    [No Abstract]   [Full Text] [Related]  

  • 74. ["Velocef squibb" in the treatment of respiratory and urinary infections (author's transl)].
    Gómez Francisco A
    Folia Clin Int (Barc); 1973 Sep; 23(9):616-21. PubMed ID: 4616857
    [No Abstract]   [Full Text] [Related]  

  • 75. [Amikacin in the treatment of genito-urinary an pulmonary infections in oncologic patients].
    Citerio P
    Minerva Med; 1991 Sep; 82(9):565-8. PubMed ID: 1945005
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Fundamental and clinical studies on cefmenoxime in the field of pediatrics].
    Toyonaga Y; Sugita M; Kawamura G; Kurosu Y; Horiuchi K; Hori M; Kohno S; Tatsusawa O; Takahashi T
    Jpn J Antibiot; 1982 Oct; 35(10):2423-39. PubMed ID: 6306294
    [No Abstract]   [Full Text] [Related]  

  • 77. [The therapeutic effect of a single administration of 1g of cefotaxime in urinary tract infections].
    Prát V; Horcicková M; Milotová Z; Matousovic K; Hatala M
    Cas Lek Cesk; 1986 Aug; 125(35):1097-9. PubMed ID: 3757001
    [No Abstract]   [Full Text] [Related]  

  • 78. [Therapeutic effect of ceftizoxime on severe infectious complications in blood disorders. Tohkai Research Group on Infections in Hematopoietic Disorders].
    Shimizu S; Hirano M; Shirakawa S; Minami N; Ohno R; Murase T; Yamamoto M; Mitomo Y; Yamada K; Shiku H
    Jpn J Antibiot; 1984 Dec; 37(12):2494-505. PubMed ID: 6098742
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Initial experience with cefotiam in respiratory and urinary tract infections].
    Havlík J
    Cesk Pediatr; 1990 Apr; 45(4):240-1. PubMed ID: 2249284
    [No Abstract]   [Full Text] [Related]  

  • 80. [Clinical evaluation of cefotaxime in complicated urinary tract infections].
    Fujii K; Fujita K; Tsukada T; Nakahara M; Kanbayashi T; Aso Y
    Jpn J Antibiot; 1983 Aug; 36(8):2073-6. PubMed ID: 6317913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.